Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Biologics : Targets & Therapy|April 18, 2014
Advancing personalized care in hemophilia A: ten years' experience with an advanced category antihemophilic factor prepared using a plasma/albumin-free methodErik Berntorp, Gerald Spotts, Lisa Patrone, et al.Molecular Biology Reports|March 26, 2004
A conserved sequence upstream of the B29 (Ig beta, CD79b) gene interacts with YY1Lisa Patrone, Sarah E Henson, Randolph Wall, et al.Molecular Immunology|January 17, 2002
Genes expressed during the IFN gamma-induced maturation of pre-B cellsLisa Patrone, Michael A Damore, Michael B Lee, et al.Experimental and Molecular Pathology|April 25, 2003
Gene expression patterns in AIDS versus non-AIDS-related diffuse large B-cell lymphomaLisa Patrone, Sarah E Henson, Jelena Teodorovic, et al.Expert Opinion on Biological Therapy|February 17, 2009
Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia AAmy Shapiro, Ralph Gruppo, Ingrid Pabinger, et al.Blood|July 10, 2015
Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia ABarbara A Konkle, Oleksandra Stasyshyn, Pratima Chowdary, et al.Nature Immunology|July 16, 2002
PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signalingThomas T Su, Beichu Guo, Yuko Kawakami, et al.Journal of Clinical Immunology|May 18, 2006
Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiencyJoseph A Church, Heinz Leibl, Mark R Stein, et al.Pageof 1